治疗挑战在管理中枢核心疾病患者的三阴性乳腺癌
Fatima Ibrahim1, Eeman Noor2, Asfandyar Khalil3
1Medicine, CMH Lahore Medical College and Institute of Dentistry, Lahore, PAK.
Cureus
|November 10, 2025
概括
患有乳腺癌的中心核心疾病 (CCD) 患者在治疗期间需要仔细监测. 本案例研究表明,化学疗法,免疫疗法和手术的成功管理没有肌肉病恶化.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 中枢核心疾病 (CCD) 是一种先天性肌肉病变,导致肌肉软弱和易患恶性热升高.
- 乳腺癌的治疗方法,如化疗和免疫疗法,可以使肌病性疾病恶化.
研究的目的:
- 报告一个成功治疗同时患有CCD和乳腺癌的案例.
- 强调监测和多学科护理两个条件的患者.
主要方法:
- 一名41岁的患有CCD和乳腺癌的女性接受了新辅助化疗和免疫疗法.
- 进行了手术和放射治疗,并对恶性热升高采取了预防措施.
- 定期监测血清肌酸激酶,肌球蛋白和阿尔多酶水平进行.
主要成果:
- 患者完成了治疗,但她的CCD没有恶化.
- 在维持免疫疗法后,她实现了缓解,并接受了预防措施的手术.
- 没有发生恶性高温症或显著的肌肉病恶化.
结论:
- 对于同时患有CCD和乳腺癌的患者来说,多学科管理和警监测至关重要.
- 早期干预和量身定制的治疗计划可以减轻与治疗相关的风险.
- 这一案例证明了在癌症患者中管理复杂的并发症的可行性.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Peripheral Artery Disease IV: Nursing Management
329
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
329
Peritoneal Dialysis III: Nursing Management
630
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
630
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


